A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

NCT03204019 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neuroendocrine Tumor

Interventions

DRUG: Tegafur and Temozolomide
DRUG: Tegafur and Temozolomide combined with Thalidomide

Sponsor

Chinese Academy of Medical Sciences